Ticker

No recent analyst price targets found for CRVL.

Latest News for CRVL

CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment

FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs. As medical billing continues to vary widely across states, providers, and…

GlobeNewsWire • Jun 17, 2026
CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth

FORT WORTH, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced that it will mark its 35th anniversary as a publicly traded company listed on the Nasdaq Stock Market. Members of the company's executive leadership team, including Chairman, President, and CEO Michael Combs, will commemorate the milestone by ringing the Nasdaq opening bell in New York City.

GlobeNewsWire • Jun 2, 2026
CorVel Q4 Earnings Call Highlights

CorVel NASDAQ: CRVL said revenue and earnings increased in its March quarter and fiscal 2026, as growth in its Network Solutions business, stronger bookings and operating efficiency helped offset a higher effective tax rate.

MarketBeat • May 20, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CRVL.

No House trades found for CRVL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top